Rockwell Medical Inc RMTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RMTI is a good fit for your portfolio.
News
-
Rockwell Medical Announces Third Quarter 2023 Results
-
Rockwell Medical Names Jesse Neri as Senior Vice President, Finance
-
Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors
-
Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023
-
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care
-
Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah
-
Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024
-
Rockwell Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023
Trading Information
- Previous Close Price
- $1.87
- Day Range
- $1.78–1.89
- 52-Week Range
- $0.94–6.24
- Bid/Ask
- $1.77 / $1.85
- Market Cap
- $50.85 Mil
- Volume/Avg
- 193,968 / 267,795
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.36
- Dividend Yield
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 253
- Website
- https://www.rockwellmed.com
Valuation
|
Metric
|
RMTI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.36 |
Price/Sales | 0.36 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RMTI
|
|---|---|
Quick Ratio | 0.99 |
Current Ratio | 1.32 |
Interest Coverage | −4.85 |
Quick Ratio
RMTI
Profitability
|
Metric
|
RMTI
|
|---|---|
Return on Assets (Normalized) | −18.48% |
Return on Equity (Normalized) | −58.07% |
Return on Invested Capital (Normalized) | −25.05% |
Return on Assets
RMTI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zqyf | $81.1 Bil | |
MKKGY
| Merck KGaA ADR | Bdxkv | $76.7 Bil | |
HLN
| Haleon PLC ADR | Hqsr | $38.9 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jjzh | $11.6 Bil | |
VTRS
| Viatris Inc | Pvmy | $11.0 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Typq | $11.0 Bil | |
CTLT
| Catalent Inc | Bhmpdd | $7.0 Bil | |
PRGO
| Perrigo Co PLC | Wpsfs | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fzvhtpj | $2.8 Bil | |
CURLF
| Curaleaf Holdings Inc | Gqh | $2.5 Bil |